Core Viewpoint - The article discusses the complexities and limitations of cancer screening, emphasizing that not all screening methods are effective and that many can lead to false positives and false negatives [1][2][3]. Group 1: Limitations of Current Screening Methods - Effective cancer screening should improve survival rates, but many existing methods do not meet this standard [2][4]. - False negatives (missed tumors) and false positives (incorrectly identified tumors) are significant issues in cancer screening, leading to unnecessary anxiety and financial burden [7][8]. - Many commonly used tumor markers are not recommended for healthy individuals due to high rates of false results [7][10]. Group 2: Recommended Screening Methods - Recommended screening methods include colonoscopy for colorectal cancer, gastroscopy for gastric cancer, low-dose spiral CT for high-risk lung cancer, mammography and ultrasound for breast cancer, and cytology and HPV testing for cervical cancer [8][11]. - The age at which screening should begin varies by cancer type, with guidelines suggesting starting at 45 for colorectal cancer and 40 for breast cancer [11][12]. Group 3: Future Directions in Cancer Screening - There is ongoing research into new screening methods, including liquid biopsies that detect cancer-related DNA in blood and the use of artificial intelligence for early tumor detection through imaging [12][13].

Core Viewpoint - The article emphasizes the importance of relying on scientific evidence regarding cancer treatment and dietary claims, urging the public to be cautious about unverified information and to follow medical advice for cancer patients [1][2]. Group 1: Cancer Myths and Dietary Claims - Many dietary claims circulating online about cancer treatment lack scientific basis, and cancer patients should adhere to medical guidelines for treatment [1]. - The National Health Commission advises the public to report health rumors or misinformation through their official platform [1]. Group 2: Tumor Markers and Diagnosis - Tumor markers are substances found in blood or bodily fluids, often elevated in cancer patients, but they should not be solely relied upon for diagnosis [2]. - Common tumor markers like alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) have limited sensitivity and specificity, meaning elevated levels do not definitively indicate cancer [2]. - If tumor markers are significantly elevated, further investigation and lifestyle adjustments under professional guidance are recommended [2]. Group 3: Nutritional Support for Cancer Patients - The goal of nutritional management for cancer patients is to prevent malnutrition, enhance treatment tolerance, and reduce adverse effects [3]. - A balanced diet with sufficient calories and quality protein intake is essential for cancer patients [3].